Chylomicron retention disease
Fredrickson’s hyperlipoproteinemia, type I or V
Hyperlipidemia, group D
Mixed hyperglyceridemia
Familial lipoprotein lipase deficiency
A genetic disorder of lipoprotein metabolism caused by mutations in the lpl and apolipoprotein apo) c-ii genes. It is characterized by increased levels of chylomicrons and triglycerides in the blood.
An inherited condition due to a deficiency of either lipoprotein lipase or apolipoprotein c-ii a lipase-activating protein). The lack of lipase activities results in inability to remove chylomicrons and triglycerides from the blood which has a creamy top layer after standing.
Intestinal fat transport defect with hypobetalipoproteinemia and accumulation of apolipoprotein b-like protein in intestinal cells, deficient blood apolipoproteins, and avitaminosis e manifested by malnutrition, steatorrhea, and growth and mental retardation. Some clinical but not biochemical) manifestations may disappear later in life.
Rare familial condition characterized by massive chylomicronemia and decreased levels of other lipoproteins; due to deficiency of lipoprotein lipase, an alkaline triglyceride hydrolase which catalyzes an important step in the extrahepatic removal of triglyceride-rich lipoproteins from the blood.
E78.3 is a billable/specific ICD-10-CM code that can be used to indicate a diagnosis for reimbursement purposes.
The 2023 edition of ICD-10-CM E78.3 became effective on October 1, 2022.
This is the American ICD-10-CM version of E78.3 – other international versions of ICD-10 E78.3 may differ.